Why we are bringing value creation back to Europe in 2026

Establishing a pharmaceutical company at a high-cost location such as Austria sometimes raises questions. From Complex Pharmaceuticals’ perspective, the answer lies in the changed requirements for supply security, quality and technological independence within the European pharmaceutical industry.

Recent years have clearly demonstrated how deeply interconnected global supply chains are, and how important robust, regionally anchored production structures have become. Against this backdrop, Complex Pharmaceuticals was founded with the ambition to design industrial processes that are efficient, flexible and regulatory compliant.

Rethinking European production
Complex Pharmaceuticals sees itself not merely as a custodian of existing structures, but as a company focused on modern production and quality processes. Regulatory security forms the foundation, but the decisive factor is the ability to combine technological flexibility with operational efficiency.

Sustainable pharmaceutical supply in Europe requires resilient industrial capacities as well as short and transparent decision-making pathways along the value chain. The aim is to align production and development processes so that they meet both high quality standards and increasing market demands.

Quality is created in the process
In the pharmaceutical industry, quality is the result of stable processes, clear responsibilities and a shared understanding of regulatory requirements. Accordingly, Complex Pharmaceuticals relies on qualified teams, interdisciplinary collaboration and a corporate culture that fosters individual accountability and professional engagement.

Especially in technology-driven production environments, flexible approaches and professional expertise are key factors for sustainable quality and efficiency.

Reliability as a location factor
As a pharmaceutical location, Austria offers high levels of expertise, stability and regulatory reliability. These conditions provide the foundation for precise and high-quality production processes.

Complex Pharmaceuticals therefore focuses on modular production structures, modern technologies and efficient workflows in order to reliably meet even complex requirements. The goal is to be recognised as a reliable partner for demanding pharmaceutical projects.

European production can remain competitive in the long term if technological expertise, quality and operational agility are consistently brought together.